ArticleAllergy2026
Urinary Leukotriene E
Abstract readLetter
In one paragraph
Article in Allergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Efficacy of Biologics in Aspirin Exacerbated Respiratory Disease.Clinical and translational allergy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Masaki OriharaDivision of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0002-8182-9800
Anthony MausDivision of Clinical Biochemistry and Immunology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0003-3006-6265
Patrick M VanderboomDivision of Clinical Biochemistry and Immunology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0003-1341-1733
Kayla MoehnkeDivision of Clinical Biochemistry and Immunology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0009-0000-9007-4211
Alessandra TomaselloDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID https://orcid.org/0009-0001-8508-7728
Katherine N CahillDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID https://orcid.org/0000-0002-8549-1835
Chien-Chang ChenDivision of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0003-2581-1830
Maria VorobevaDivision of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0002-6579-6869
Aleksandr iAkushevDivision of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0009-0001-7040-7792
Sergio E ChiarellaDivision of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0002-0445-4929
Kimberly G BlumenthalDivision of Pulmonary, Allergy and Sleep Medicine, Mayo Clinic, Jacksonville, Florida, USA.ORCID https://orcid.org/0000-0003-4773-9817
Janalee K StokkenDepartment of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0002-1402-7461
Jacob G EideDepartment of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0003-3727-8287
Rijul S KshirsagarDepartment of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0002-3113-2685
Nadeem AkbarDepartment of Otolaryngology-Head and Neck Surgery, Montefiore Medical Center, Bronx, New York, USA.ORCID https://orcid.org/0000-0001-6108-6985
Patrick ColleyDepartment of Otolaryngology-Head and Neck Surgery, Montefiore Medical Center, Bronx, New York, USA.ORCID https://orcid.org/0009-0007-8304-7339
Golda HudesDivision of Allergy and Immunology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.ORCID https://orcid.org/0000-0002-4656-7753
Erin K O'BrienDepartment of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0002-4891-9548
Hirohito KitaDivision of Allergy, Asthma, and Clinical Immunology, Mayo Clinic, Scottsdale, Arizona, USA.ORCID https://orcid.org/0000-0002-6854-2936
Rohit DivekarDivision of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0003-3836-1322
Hamid R TizhooshDepartment of Artificial Intelligence & Informatics, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0001-5488-601X
Diane E GrillDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0002-8677-1724
Elina JerschowDivision of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0002-9066-2483
Funding
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic AsthmaU01AI155299 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CAHILL, KATHERINE N · 2021 to 2025
$8.6MGLP-1R agonist immune targets in lean and obesity-associated asthmaR01AI182159 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Katherine N Cahill · 2024 to 2026
$2.6MTh2A cells mediate outcomes of aspirin-exacerbated respiratory diseaseR21AI146804 · NIAID · MAYO CLINIC ROCHESTER · PI JERSCHOW, ELINA · 2020 to 2021
$456kStaphylococcus aureus and eicosanoid dysregulation as drivers of inflammation in aspirin-exacerbated respiratory diseaseR21AI171306 · NIAID · MAYO CLINIC ROCHESTER · PI JERSCHOW, ELINA · 2024 to 2025
$444kMayo ClinicNational Institute of Allergy and Infectious Diseases R01AI182159National Institute of Allergy and Infectious Diseases R21AI146804National Institute of Allergy and Infectious Diseases R21AI171306National Institute of Allergy and Infectious Diseases U01AI155299NIAID NIH HHS R01 AI182159NIAID NIH HHS R21 AI146804NIAID NIH HHS R21 AI171306NIAID NIH HHS U01 AI155299
Abstract
PubMed holds no abstract for this paper.
Indexed as
chronic rhinosinusitis with nasal polypsdiagnostic biomarkerNSAID‐exacerbated respiratory diseasesinus surgeryurinary leukotriene E4
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.